ChemoCentryx
CCXI
#3216
Rank
โ‚ฌ3.37 B
Marketcap
46,92ย โ‚ฌ
Share price
0.00%
Change (1 day)
29.54%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): โ‚ฌ33.44 M

According to ChemoCentryx's latest financial reports the company's current revenue (TTM) is โ‚ฌ33.56 M. In 2021 the company made a revenue of โ‚ฌ28.03 M a decrease over the revenue in the year 2020 that were of โ‚ฌ52.67 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ33.44 M19.27%
2021 โ‚ฌ28.03 M-46.77%
2020 โ‚ฌ52.67 M64.52%
2019 โ‚ฌ32.01 M-14.45%
2018 โ‚ฌ37.42 M-45.56%
2017 โ‚ฌ68.75 M532.45%
2016 โ‚ฌ10.87 M
2015 N/A
2014 N/A-100%
2013 โ‚ฌ4.38 M6.99%
2012 โ‚ฌ4.1 M-83.19%
2011 โ‚ฌ24.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ8.72 B 25,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ49.63 B 147,749.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.61 B 105,993.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ41.96 B 124,924.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.12 B 232,631.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.91 B 83,055.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.21 B 149,475.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.70 B 43,690.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ56.38 B 167,854.30%๐Ÿ‡บ๐Ÿ‡ธ USA